Kalaris Therapeutics, Inc. KLRS
1.35 USD -0.02 (-1.46%)
Regular-session close
1.35 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
1.33 Day range 1.39
1.33 52-week range 11.88
- YTD
- -84.00%
- 1 year
- -79.79%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -46.15M | -51.73M | -199.90M | -171.20M | -169.82M | |
| -43.44M | -69.17M | -190.42M | -168.71M | -171.96M | |
| -2.85 | -51.77 | -42.09 | -51.00 | -63.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 98.55M | 1.64M | 90.97M | 106.94M | 202.51M | |
| 121.74M | 6.16M | 190.80M | 277.08M | 286.59M | |
| 42.92M | 56.78M | 45.02M | 52.56M | 61.33M | |
| 1.45M | 19.54M | 27.43M | 35.39M | 30.07M | |
| 78.81M | -96.62M | 145.78M | 224.52M | 225.27M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -38.37M | -20.67M | -124.45M | -142.05M | -106.32M | |
| -19.72M | 0 | 37.98M | -80.48M | 185.98M | |
| 155.01M | 19.14M | 70.50M | 126.96M | 232.00K | |
| -200.00K | 0 | 0 | 0 | -26.00K | |
| 96.91M | -1.53M | -15.97M | -95.57M | 79.85M |
